|
S.N. Nedvetskaya, V.G. Tregubov, I.Z. Shubitidze, M.V. Tregubova
Influence of angiotensin-converting enzyme inhibitors on the structural and functional parameters of the heart and subjective parameters of the quality of life of patients with essential hypertension
|
№1-2 / 2023
|
|
D.V. Nebieridze (1), T.V. Kamyshova (1), A.A. Sarycheva (2)
EVALUATION OF FREQUENCY OF TARGET ORGAN DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION WHO APPLIED FOR AN OUTPATIENT APPOINTMENT WITH A DOCTOR FOR THE FIRST TIME
|
№9 / 2016
|
|
A.S. Adamchik, D.I. Panchenko
INCREASED THYROID-STIMULATING HORMONE LEVEL AS A MARKER OF PROGRESSION OF HEART FAILURE IN CARDIAC PATIENTS
|
№5 / 2016
|
|
V.N. Shishkova
EFFECTIVE SOLUTION OF PROBLEM OF ANTIHYPERTENSIVE THERAPY IN PATIENT WITH CHRONIC CEREBRAL ISCHEMIA
|
№18 / 2013
|
|
V.V.Fomin, A.A. Svistunov
BETA-BLOCKERS AND HYPERTENSION: ARE THERE INSURMOUNTABLE LIMITS?
|
№9 / 2013
|
|
S.I. Ovcharenko, Z.N. Nersesyan
Approaches To The Treatment Of Hypertension In Patients With Chronic Obstructive Pulmonary Disease
|
№4 / 2013
|
|
S.Nedogoda, A. Ledyaeva, V. Choma, E. Chumakov, I. Barykina
Central Pressure In The Aorta As A Target For Antihypertensive Therapy
|
№20 / 2011
|
|
V.Ye. Volkov
Atrial Fibrillation Associated With Arterial Hypertension
|
№14 / 2011
|
|
A.M. Shilov, A.O. Osia, M.S. Dulayeva, I.V. Yeremina
Pathophysiological Features Of Treatment Of Arterial Hypertension And Disorders Of Carbohydrate Metabolism
|
№5 / 2011
|
|
M.V. Melnik, A.M. Shilov
Arterial Hypertension And Potentials For Use Of ?-blockers
|
№13 / 2010
|
|
Sbrodova L. V., Volkov V.Y., Pshenitsin A. I., Kostoeva A. U., Mazur N. A. С. 7681
Dynamics Of Heart Rate Variability Under Pressure Of Therapy With Sotalol And Verapamil In Hypertensive Patients With Atrial Fibrillation Paroxysms
|
№20 / 2009
|
|
M.Leonova С. 3642
Clinical Significance Of Oral Dosage Form Of Alpha1-blockers With Modified Release In Management Of Patients With Benign Prostatic Hypertrophy
|
№20 / 2009
|
Русский
